Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy
Clinical trial NCT02631096 · COMPLETED
Trial details
- NCT number
- NCT02631096
- Sponsor
- Arbutus Biopharma Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-05-18
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.